Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CardieX ( (AU:CDX) ) has issued an update.
Cardiex Limited announced the results of its Extraordinary General Meeting held on September 17, 2025, where all proposed resolutions were passed. This outcome supports the company’s strategic initiatives, including share placements and long-term incentives for directors and employees, potentially strengthening its market position and stakeholder confidence.
More about CardieX
Cardiex is a company focused on advancing medical technology for vascular health, offering products such as medical and home health devices and digital solutions for conditions like hypertension and cardiovascular disease. Their products are based on the SphygmoCor® vascular biomarker technology, and the company is listed on the Australian Stock Exchange (ASX: CDX).
Average Trading Volume: 469,043
Technical Sentiment Signal: Sell
Current Market Cap: A$15.95M
For detailed information about CDX stock, go to TipRanks’ Stock Analysis page.